FDA notifications. Revised atazanavir package insert.
D000069446:Atazanavir Sulfate; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004347:Drug Interactions; D004348:Drug Labeling; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D009842:Oligopeptides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate